The most common toxicities were diarrhoea ( @ -LSB- @ % -RSB- of @ patients on gefitinib vs six -LSB- @ % -RSB- of @ on placebo ) and skin toxicity ( @ -LSB- @ % -RSB- vs two -LSB- @ % -RSB- ) , both mostly grade @ .